ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2721

Patients’ Perspective of Skin Involvement in Systemic Sclerosis

Ada Man1, Amy Wu1, Jessica Ziemek2, Romy Christmann1, Robert W. Simms1, David T. Felson3 and Robert Lafyatis4, 1Rheumatology, Boston University School of Medicine, Boston, MA, 2Rheumatology/Arthritis Center, Boston University School of Medicine, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Arthritis Center, Boston University, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: patient outcomes, quality of life, skin and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Determinants of Disease, Classification and Response

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Skin tightness and other abnormalities of the skin are the hallmark features of systemic sclerosis (SSc).  While skin involvement may significantly impact a patient’s quality of life, this impact is not well understood since current measures of SSc disease activity only address the objective measure of skin thickness (modified Rodnan skin score), and non-skin related SSc health status (scleroderma HAQ, SSc-GIT).  We sought to identify key items of concern as related to skin disease in SSc from the patient’s perspective.

Methods:   Three directed focus groups with diffuse and limited cutaneous SSc patients (N=15) were conducted to facilitate free discussion around the patients’ experience with skin-related quality of life in SSc.  Transcripts were qualitatively analyzed using a Grounded Theory approach and emerging items of concern were coded with the aid of data analysis software (NVivo 10, QSR International).  The items were sorted according to their frequency of citation combining all three focus sessions.  We identified major constructs that formed a unifying conceptual framework for the items.

Results:   The top cited concerns by patients included difficulty with gripping and moving parts of the body due to skin tightness, feeling self-conscious about the skin’s appearance, uncomfortable skin tightness/restrictiveness, and difficulty opening and closing the mouth.  Some skin-related concerns such as hand function may overlap with musculoskeletal involvement in SSc.  Four major constructs were identified (in descending order of cited frequency): physical limitations imposed by skin tightness, physical skin effects, emotional effects, and social effects. 

Conclusion:   The subjective effects of skin involvement on SSc patients’ quality of life are multidimensional and some important patient concerns such as discomfort from skin tightness, itch, and reduced mouth opening are not captured by existing disease outcome instruments in the dermatology and rheumatology literature.  Hand function was a frequently cited skin-related concern and points to a possible need for SSc specific hand function assessment instruments as well.

Table 1. Top 20 concerns cited by systemic sclerosis patients (N=15) during three focus sessions relating to how skin affects their quality of life

Construct

Item

Number of times cited

Physical limitations

Difficulty with grip/fist

46

Physical limitations

Difficulty moving parts of the body

26

Emotional effects

Self-conscious

24

Physical skin effects

Tight or Restrictive

21

Physical limitations

Reduced ability to close or open mouth

18

Physical limitations

Difficulty with fine motor skills

18

Emotional effects

Fear of not knowing how disease will progress

14

Physical limitations

Difficulty putting on clothes and shoes

11

Physical skin effects

Itchy

11

Physical skin effects

Skin darkening

10

Physical skin effects

Swelling of skin on hands and fingers

10

Physical skin effects

Dry

7

Physical skin effects

Tingling or burning

6

Emotional effects

Depressed

6

Emotional effects

Different sense of self

6

Physical limitations

Difficulty opening hands

5

Physical skin effects

Change in facial appearance

5

Social effects

Decreased ability to work

5

Emotional effects

Feel misjudged by looks

4

Physical limitations

Change in ability and comfort in doing sports

4

 


Disclosure:

A. Man,
None;

A. Wu,
None;

J. Ziemek,
None;

R. Christmann,
None;

R. W. Simms,
None;

D. T. Felson,
None;

R. Lafyatis,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-perspective-of-skin-involvement-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology